Abstract
Risk equations based on the Framingham Heart Study (FHS) are used in NZ to predict the 5y risk of incident cardiovascular (CV) events. OBJECTIVE: To establish how well the FHS equations predict first hospitalisation or mortality from CV events in a New Zealand (NZ) population without overt CV disease. METHODS: Observations were taken from a cohort study with 6354 (4638 M +1716 F) participants age 32–74 without known CV disease, taken from the workforce of a nation-wide multi-industry corporation plus a random sample of the Auckland electoral rolls. Prognostic factors were assessed in 1992/93 by a questionnaire plus physiological measurements (BP, cholesterol etc.). Age-specific risk predictions from the FHS were compared with age-specific mortality plus relevant hospital discharges from January 1988 to December 1998 (NZ Health Information Service). RESULTS: The 5y incidence of first hospitalisation for any CV event was 6.4% (male) and 4.4% (female). Table 1 compares observed hospitalised events or mortality with predicted incident events, averaged across 5y age bands. CONCLUSIONS: FHS risk equations accurately predict age-specific incident hospitalized CHD or stroke events or mortality for NZ males age 30–74 but under-estimate MI events. Prediction is less accurate and precise for females. Ratio of observed to predicted events, averaged across 8 × 5y age bands Mean ratio (±SD) Male Female Both CHD 1.03 ± 0.15 0.92 ± 0.35 1.03 ± 0.06 MI 1.24 ± 0.19 1.49 ± 1.19 1.26 ± 0.15 STROKE 0.98 ± 0.40 0.74 ± 0.57 0.94 ± 0.42
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.